Pub Date : 2024-09-17DOI: 10.1007/s11547-024-01889-6
Christian Booz, Giuseppe M. Bucolo, Tommaso D’Angelo, Silvio Mazziotti, Ludovica R. M. Lanzafame, Ibrahim Yel, Leona S. Alizadeh, Leon D. Gruenewald, Vitali Koch, Simon S. Martin, Mirela Dimitrova, Aynur Goekduman, Thomas J. Vogl, Hanns L. Kaatsch, Daniel Overhoff, Stephan Waldeck
Purpose
Preliminary dual-energy CT studies have shown that low-energy virtual monoenergetic (VMI) + reconstructions can provide superior image quality compared to standard 120 kV CTA series. The purpose of this study is to evaluate the impact of low-energy VMI reconstructions on quantitative and qualitative image quality, vascular contrast, and diagnostic assessability of the carotid artery in patients undergoing photon-counting CTA examinations.
Materials and methods
A total of 122 patients (67 male) who had undergone dual-source photon-counting CTA scans of the carotid artery were retrospectively analyzed in this study. Standard 120 kV CT images and low-keV VMI series from 40 to 100 keV with an interval of 15 keV were reconstructed. Quantitative analyses included the evaluation of vascular CT numbers, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). CT number measurements were performed in the common, external, and internal carotid arteries. Qualitative analyses were performed by three board-certified radiologists independently using five-point scales to evaluate image quality, vascular contrast, and diagnostic assessability of the carotid artery.
Results
Mean attenuation, CNR and SNR values were highest in 40 keV VMI reconstructions (HU, 1362.32 ± 457.81; CNR, 33.19 ± 12.86; SNR, 34.37 ± 12.89) followed by 55-keV VMI reconstructions (HU, 736.94 ± 150.09; CNR, 24.49 ± 7.11; SNR, 26.25 ± 7.34); all three mean values at these keV levels were significantly higher compared with the remaining VMI series and standard 120 kV CT series (HU, 154.43 ± 23.69; CNR, 16.34 ± 5.47; SNR, 24.44 ± 7.14) (p < 0.0001).
The qualitative analysis showed the highest rating scores for 55 keV VMI reconstructions followed by 40 keV and 70 keV VMI series with a significant difference compared to standard 120 kV CT images series regarding image quality, vascular contrast, and diagnostic assessability of the carotid artery (all comparisons, p < 0.01).
Conclusions
Low-keV VMI reconstructions at a level of 40–55 keV significantly improve image quality, vascular contrast, and the diagnostic assessability of the carotid artery compared with standard CT series in photon-counting CTA.
{"title":"Carotid artery assessment in dual-source photon-counting CT: impact of low-energy virtual monoenergetic imaging on image quality, vascular contrast and diagnostic assessability","authors":"Christian Booz, Giuseppe M. Bucolo, Tommaso D’Angelo, Silvio Mazziotti, Ludovica R. M. Lanzafame, Ibrahim Yel, Leona S. Alizadeh, Leon D. Gruenewald, Vitali Koch, Simon S. Martin, Mirela Dimitrova, Aynur Goekduman, Thomas J. Vogl, Hanns L. Kaatsch, Daniel Overhoff, Stephan Waldeck","doi":"10.1007/s11547-024-01889-6","DOIUrl":"https://doi.org/10.1007/s11547-024-01889-6","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Preliminary dual-energy CT studies have shown that low-energy virtual monoenergetic (VMI) + reconstructions can provide superior image quality compared to standard 120 kV CTA series. The purpose of this study is to evaluate the impact of low-energy VMI reconstructions on quantitative and qualitative image quality, vascular contrast, and diagnostic assessability of the carotid artery in patients undergoing photon-counting CTA examinations.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>A total of 122 patients (67 male) who had undergone dual-source photon-counting CTA scans of the carotid artery were retrospectively analyzed in this study. Standard 120 kV CT images and low-keV VMI series from 40 to 100 keV with an interval of 15 keV were reconstructed. Quantitative analyses included the evaluation of vascular CT numbers, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). CT number measurements were performed in the common, external, and internal carotid arteries. Qualitative analyses were performed by three board-certified radiologists independently using five-point scales to evaluate image quality, vascular contrast, and diagnostic assessability of the carotid artery.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Mean attenuation, CNR and SNR values were highest in 40 keV VMI reconstructions (HU, 1362.32 ± 457.81; CNR, 33.19 ± 12.86; SNR, 34.37 ± 12.89) followed by 55-keV VMI reconstructions (HU, 736.94 ± 150.09; CNR, 24.49 ± 7.11; SNR, 26.25 ± 7.34); all three mean values at these keV levels were significantly higher compared with the remaining VMI series and standard 120 kV CT series (HU, 154.43 ± 23.69; CNR, 16.34 ± 5.47; SNR, 24.44 ± 7.14) (<i>p</i> < 0.0001).</p><p>The qualitative analysis showed the highest rating scores for 55 keV VMI reconstructions followed by 40 keV and 70 keV VMI series with a significant difference compared to standard 120 kV CT images series regarding image quality, vascular contrast, and diagnostic assessability of the carotid artery (all comparisons, <i>p</i> < 0.01).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Low-keV VMI reconstructions at a level of 40–55 keV significantly improve image quality, vascular contrast, and the diagnostic assessability of the carotid artery compared with standard CT series in photon-counting CTA.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142268571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-16DOI: 10.1007/s11547-024-01877-w
Pierleone Lucatelli, Bianca Rocco, Renato Argirò, Vittorio Semeraro, Quirino Lai, Elena Bozzi, Sara Crociati, Michele Barone, Alessandro Posa, Carlo Catalano, Laura Crocetti, Roberto Iezzi
Introduction
Percutaneous thermal segmentectomy is a single-step combination of microwave ablation, performed during arterial occlusion obtained with a balloon micro catheter, followed in the same session by balloon-occluded TACE. The aim of this multicenter retrospective study is to report the mid-term oncological performance of this technique for liver malignancies > 3.0 cm and to identify risk factors for the loss of sustained complete response.
Methods
Oncological results were evaluated with CT or MRI according to m-RECIST (HCC) and RECISTv1.1 (metastasis/intra-hepatic cholangiocarcinoma, iCC) at 1-month, 3–6-month and then at regular-6-month intervals. To identify predictive variables associated with not achieving or losing complete response two mixed-effects multivariable logistic regression models were constructed.
Results
Sixty-three patients (40/23, male/female) with primary liver malignancies (HCC = 49; iCC = 4) and metastasis (n = 10) were treated. Median diameter of target lesion was 4.5 cm (range 3.0–7.0 cm). The median follow-up time was 9.2 months. At one-month follow-up, 79.4% of patients presented with a complete response and the remaining 20.6% were partial responders. At the 3–6-month follow-up, reached by 59 of the initial 63 patients, 83.3% showed a sustained complete response, while 10.2% had a partial response and 8.5% a local recurrence. At the last follow-up, 69.8% of the lesions showed a complete response. The initial diameter of the target lesion ≥ 5.0 cm was the only independent variable associated with the risk of failure in maintaining a complete response at 6 months (OR = 8.58, 95% CI 1.38–53.43; P = 0.02).
Conclusion
Percutaneous thermal segmentectomy achieves promising oncological results in patients with tumors > 3.0 cm, with tumor dimension ≥ 5.0 cm being the only risk factor associated with the failure of a sustained complete response.
{"title":"Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response from a multicentric Italian retrospective study","authors":"Pierleone Lucatelli, Bianca Rocco, Renato Argirò, Vittorio Semeraro, Quirino Lai, Elena Bozzi, Sara Crociati, Michele Barone, Alessandro Posa, Carlo Catalano, Laura Crocetti, Roberto Iezzi","doi":"10.1007/s11547-024-01877-w","DOIUrl":"https://doi.org/10.1007/s11547-024-01877-w","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Percutaneous thermal segmentectomy is a single-step combination of microwave ablation, performed during arterial occlusion obtained with a balloon micro catheter, followed in the same session by balloon-occluded TACE. The aim of this multicenter retrospective study is to report the mid-term oncological performance of this technique for liver malignancies > 3.0 cm and to identify risk factors for the loss of sustained complete response.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Oncological results were evaluated with CT or MRI according to m-RECIST (HCC) and RECISTv1.1 (metastasis/intra-hepatic cholangiocarcinoma, iCC) at 1-month, 3–6-month and then at regular-6-month intervals. To identify predictive variables associated with not achieving or losing complete response two mixed-effects multivariable logistic regression models were constructed.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Sixty-three patients (40/23, male/female) with primary liver malignancies (HCC = 49; iCC = 4) and metastasis (n = 10) were treated. Median diameter of target lesion was 4.5 cm (range 3.0–7.0 cm). The median follow-up time was 9.2 months. At one-month follow-up, 79.4% of patients presented with a complete response and the remaining 20.6% were partial responders. At the 3–6-month follow-up, reached by 59 of the initial 63 patients, 83.3% showed a sustained complete response, while 10.2% had a partial response and 8.5% a local recurrence. At the last follow-up, 69.8% of the lesions showed a complete response. The initial diameter of the target lesion ≥ 5.0 cm was the only independent variable associated with the risk of failure in maintaining a complete response at 6 months (OR = 8.58, 95% CI 1.38–53.43; <i>P</i> = 0.02).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Percutaneous thermal segmentectomy achieves promising oncological results in patients with tumors > 3.0 cm, with tumor dimension ≥ 5.0 cm being the only risk factor associated with the failure of a sustained complete response.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-11DOI: 10.1007/s11547-024-01888-7
Dawon Park, Chansik An, Jeong-Sik Yu
Purpose
To investigate the association between metabolic syndrome and perirenal fat stranding (PRFS), which is defined as linear or curvilinear soft tissue densities in the perirenal fat on computed tomography (CT).
Material and Methods
Adults who had abdominal CT for health screening at a single institution between October 2022 and March 2023 were included retrospectively. Two radiologists assessed the extent of PRFS for each CT and graded it as absent, mild/moderate, and severe. Logistic regression analyses were used to investigate the associations between PRFS and metabolic syndrome-related factors, as well as age and gender.
Results
Among 701 participants (mean age, 56.8 years ± 9.7; 336 women and 365 men), 87 (12.4%) had mild (n = 80) or moderate (n = 7) PRFS. None had severe PRFS. The presence of PRFS was independently associated with higher body mass index (odds ratio [OR], 2.561 and 9.842 for overweight and obese, respectively; p ≤ 0.001), elevated blood pressure with or without anti-hypertensive medication (OR, 2.232; p = 0.015), anti-diabetic medication (OR, 3.129; p < 0.001), and lipid-lowering medication (OR, 1.919; p = 0.019), older age (OR, 4.545 and 9.109 for 50–59 years and ≥ 60 years, respectively; p ≤ 0.002), and male gender (OR, 10.065; p < 0.001). Sixty three of 87 (72.4%) participants with PRFS had metabolic syndrome, while 265 of 614 (43.2%) participants without PRFS did (p < 0.001).
Conclusion
Incidental mild or moderate PRFS may be associated with the presence of metabolic syndrome or related disorders in otherwise healthy adults.
{"title":"Association between incidental perirenal fat stranding on CT and metabolic syndrome in otherwise healthy adults","authors":"Dawon Park, Chansik An, Jeong-Sik Yu","doi":"10.1007/s11547-024-01888-7","DOIUrl":"https://doi.org/10.1007/s11547-024-01888-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>To investigate the association between metabolic syndrome and perirenal fat stranding (PRFS), which is defined as linear or curvilinear soft tissue densities in the perirenal fat on computed tomography (CT).</p><h3 data-test=\"abstract-sub-heading\">Material and Methods</h3><p>Adults who had abdominal CT for health screening at a single institution between October 2022 and March 2023 were included retrospectively. Two radiologists assessed the extent of PRFS for each CT and graded it as absent, mild/moderate, and severe. Logistic regression analyses were used to investigate the associations between PRFS and metabolic syndrome-related factors, as well as age and gender.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among 701 participants (mean age, 56.8 years ± 9.7; 336 women and 365 men), 87 (12.4%) had mild (<i>n</i> = 80) or moderate (<i>n</i> = 7) PRFS. None had severe PRFS. The presence of PRFS was independently associated with higher body mass index (odds ratio [OR], 2.561 and 9.842 for overweight and obese, respectively; <i>p</i> ≤ 0.001), elevated blood pressure with or without anti-hypertensive medication (OR, 2.232; <i>p</i> = 0.015), anti-diabetic medication (OR, 3.129; <i>p</i> < 0.001), and lipid-lowering medication (OR, 1.919; <i>p</i> = 0.019), older age (OR, 4.545 and 9.109 for 50–59 years and ≥ 60 years, respectively; <i>p</i> ≤ 0.002), and male gender (OR, 10.065; <i>p</i> < 0.001). Sixty three of 87 (72.4%) participants with PRFS had metabolic syndrome, while 265 of 614 (43.2%) participants without PRFS did (<i>p</i> < 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Incidental mild or moderate PRFS may be associated with the presence of metabolic syndrome or related disorders in otherwise healthy adults.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"130 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-10DOI: 10.1007/s11547-024-01883-y
Alessandra Borgheresi, Elisa Cesari, Andrea Agostini, Myriam Badaloni, Sofia Balducci, Elisabetta Tola, Valeria Consoli, Andrea Palucci, Luca Burroni, Marina Carotti, Andrea Giovagnoni
Aim
To assess the correlation of quantitative data of pulmonary Perfused Blood Volume (PBV) on Dual-Energy CT (DECT) datasets in patients with moderate – severe Pulmonary Emphysema (PE) with Lung Perfusion Scintigraphy (LPS) as the reference standard. The secondary endpoints are the correlation between the CT densitometric analysis and the visual assessment of parenchymal destruction with PBV.
Materials and Methods
Patients with moderate – severe PE candidate to Lung Volumetric Reduction (LVR), with available a pre-procedural LS and a contrast-enhanced DECT were retrospectively included. DECT studies were performed with a 3rd generation Dual-Source CT and the PBV was obtained with a 3-material decomposition algorithm. The CT densitometric analysis was performed with a dedicated commercial software (Pulmo3D). The Goddard Score was used for visual assessment. The perfusion LS were performed after the administration of albumin macroaggregates labeled with 99mTechnetium. The image revision was performed by two radiologists or nuclear medicine physicians blinded, respectively, to LS and DECT data. The statistical analysis was performed with nonparametric tests.
Results
Thirty-one patients (18 males, median age 69 y.o., interquartile range 62–71 y.o.) with moderate – severe PE (Median Goddard Score 14/20 and 31% of emphysematous parenchyma at quantitative CT) candidate to LVR were retrospectively included. The median enhancement on PBV was 17 HU. Significant correlation coefficients were demonstrated between lung PBV and LS, poor in apical regions (Rho = 0.1–0.2) and fair (Rho = 0.3–0.5) in middle and lower regions. No significant correlations were recorded between the CT densitometric analysis, the visual score, and the PBV.
Conclusions
Lung perfusion with PBV on DECT is feasible in patients with moderate – severe PE candidate to LVR, and has a poor to fair agreement with LPS.
{"title":"Pulmonary emphysema: the assessment of lung perfusion with Dual-Energy CT and pulmonary scintigraphy","authors":"Alessandra Borgheresi, Elisa Cesari, Andrea Agostini, Myriam Badaloni, Sofia Balducci, Elisabetta Tola, Valeria Consoli, Andrea Palucci, Luca Burroni, Marina Carotti, Andrea Giovagnoni","doi":"10.1007/s11547-024-01883-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01883-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Aim</h3><p>To assess the correlation of quantitative data of pulmonary Perfused Blood Volume (PBV) on Dual-Energy CT (DECT) datasets in patients with moderate – severe Pulmonary Emphysema (PE) with Lung Perfusion Scintigraphy (LPS) as the reference standard. The secondary endpoints are the correlation between the CT densitometric analysis and the visual assessment of parenchymal destruction with PBV.</p><h3 data-test=\"abstract-sub-heading\">Materials and Methods</h3><p>Patients with moderate – severe PE candidate to Lung Volumetric Reduction (LVR), with available a pre-procedural LS and a contrast-enhanced DECT were retrospectively included. DECT studies were performed with a 3rd generation Dual-Source CT and the PBV was obtained with a 3-material decomposition algorithm. The CT densitometric analysis was performed with a dedicated commercial software (Pulmo3D). The Goddard Score was used for visual assessment. The perfusion LS were performed after the administration of albumin macroaggregates labeled with <sup>99m</sup>Technetium. The image revision was performed by two radiologists or nuclear medicine physicians blinded, respectively, to LS and DECT data. The statistical analysis was performed with nonparametric tests.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Thirty-one patients (18 males, median age 69 y.o., interquartile range 62–71 y.o.) with moderate – severe PE (Median Goddard Score 14/20 and 31% of emphysematous parenchyma at quantitative CT) candidate to LVR were retrospectively included. The median enhancement on PBV was 17 HU. Significant correlation coefficients were demonstrated between lung PBV and LS, poor in apical regions (Rho = 0.1–0.2) and fair (Rho = 0.3–0.5) in middle and lower regions. No significant correlations were recorded between the CT densitometric analysis, the visual score, and the PBV.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Lung perfusion with PBV on DECT is feasible in patients with moderate – severe PE candidate to LVR, and has a poor to fair agreement with LPS.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-03DOI: 10.1007/s11547-024-01859-y
Marta Tagliabue, Francesca Ruju, Chiara Mossinelli, Aurora Gaeta, Sara Raimondi, Stefania Volpe, Mattia Zaffaroni, Lars Johannes Isaksson, Cristina Garibaldi, Marta Cremonesi, Anna Rapino, Susanna Chiocca, Giacomo Pietrobon, Daniela Alterio, Giuseppe Trisolini, Patrizia Morbini, Vittorio Rampinelli, Alberto Grammatica, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa, Lorenzo Preda, Marco Ravanelli, Roberto Maroldi, Cesare Piazza, Marco Benazzo, Mohssen Ansarin
Purpose
Radiomics is an emerging field that utilizes quantitative features extracted from medical images to predict clinically meaningful outcomes. Validating findings is crucial to assess radiomics applicability. We aimed to validate previously published magnetic resonance imaging (MRI) radiomics models to predict oncological outcomes in oral tongue squamous cell carcinoma (OTSCC).
Materials and methods
Retrospective multicentric study on OTSCC surgically treated from 2010 to 2019. All patients performed preoperative MRI, including contrast-enhanced T1-weighted (CE-T1), diffusion-weighted sequences and apparent diffusion coefficient map. We evaluated overall survival (OS), locoregional recurrence-free survival (LRRFS), cause-specific mortality (CSM). We elaborated different models based on clinical and radiomic data. C-indexes assessed the prediction accuracy of the models.
Results
We collected 112 consecutive independent patients from three Italian Institutions to validate the previously published MRI radiomic models based on 79 different patients. The C-indexes for the hybrid clinical-radiomic models in the validation cohort were lower than those in the training cohort but remained > 0.5 in most cases. CE-T1 sequence provided the best fit to the models: the C-indexes obtained were 0.61, 0.59, 0.64 (pretreatment model) and 0.65, 0.69, 0.70 (posttreatment model) for OS, LRRFS and CSM, respectively.
Conclusion
Our clinical-radiomic models retain a potential to predict OS, LRRFS and CSM in heterogeneous cohorts across different centers. These findings encourage further research, aimed at overcoming current limitations, due to the variability of imaging acquisition, processing and tumor volume delineation.
目的 放射组学是一个新兴领域,它利用从医学影像中提取的定量特征来预测具有临床意义的结果。验证研究结果对于评估放射组学的适用性至关重要。我们旨在验证之前发表的磁共振成像(MRI)放射组学模型,以预测口腔舌鳞状细胞癌(OTSCC)的肿瘤预后。所有患者均进行了术前 MRI 检查,包括对比增强 T1 加权(CE-T1)、弥散加权序列和表观弥散系数图。我们评估了总生存率(OS)、无局部复发生存率(LRRFS)和特异性死亡率(CSM)。我们根据临床和放射学数据建立了不同的模型。结果我们从意大利三家机构收集了112名连续的独立患者,对之前发表的基于79名不同患者的磁共振成像放射学模型进行了验证。验证队列中临床-放射学混合模型的 C 指数低于训练队列中的 C 指数,但在大多数情况下仍为 > 0.5。CE-T1序列为模型提供了最佳拟合度:对于OS、LRRFS和CSM,获得的C指数分别为0.61、0.59、0.64(治疗前模型)和0.65、0.69、0.70(治疗后模型)。这些发现鼓励了进一步的研究,旨在克服目前由于成像采集、处理和肿瘤体积划分的可变性而造成的局限性。
{"title":"The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study","authors":"Marta Tagliabue, Francesca Ruju, Chiara Mossinelli, Aurora Gaeta, Sara Raimondi, Stefania Volpe, Mattia Zaffaroni, Lars Johannes Isaksson, Cristina Garibaldi, Marta Cremonesi, Anna Rapino, Susanna Chiocca, Giacomo Pietrobon, Daniela Alterio, Giuseppe Trisolini, Patrizia Morbini, Vittorio Rampinelli, Alberto Grammatica, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa, Lorenzo Preda, Marco Ravanelli, Roberto Maroldi, Cesare Piazza, Marco Benazzo, Mohssen Ansarin","doi":"10.1007/s11547-024-01859-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01859-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Radiomics is an emerging field that utilizes quantitative features extracted from medical images to predict clinically meaningful outcomes. Validating findings is crucial to assess radiomics applicability. We aimed to validate previously published magnetic resonance imaging (MRI) radiomics models to predict oncological outcomes in oral tongue squamous cell carcinoma (OTSCC).</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>Retrospective multicentric study on OTSCC surgically treated from 2010 to 2019. All patients performed preoperative MRI, including contrast-enhanced T1-weighted (CE-T1), diffusion-weighted sequences and apparent diffusion coefficient map. We evaluated overall survival (OS), locoregional recurrence-free survival (LRRFS), cause-specific mortality (CSM). We elaborated different models based on clinical and radiomic data. C-indexes assessed the prediction accuracy of the models.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>We collected 112 consecutive independent patients from three Italian Institutions to validate the previously published MRI radiomic models based on 79 different patients. The C-indexes for the hybrid clinical-radiomic models in the validation cohort were lower than those in the training cohort but remained > 0.5 in most cases. CE-T1 sequence provided the best fit to the models: the C-indexes obtained were 0.61, 0.59, 0.64 (pretreatment model) and 0.65, 0.69, 0.70 (posttreatment model) for OS, LRRFS and CSM, respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our clinical-radiomic models retain a potential to predict OS, LRRFS and CSM in heterogeneous cohorts across different centers. These findings encourage further research, aimed at overcoming current limitations, due to the variability of imaging acquisition, processing and tumor volume delineation.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141883391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-29DOI: 10.1007/s11547-024-01821-y
Antonella Meloni, Laura Pistoia, Paolo Ricchi, Filomena Longo, Valerio Cecinati, Francesco Sorrentino, Liana Cuccia, Elisabetta Corigliano, Vincenza Rossi, Riccardo Righi, Priscilla Fina, Stefania Renne, Luigi Barbuto, Vincenzo Positano, Filippo Cademartiri
Purpose
In a relatively large cohort of thalassemia intermedia (TI) patients, we systematically investigated myocardial iron overload (MIO), function, and replacement fibrosis using cardiac magnetic resonance (CMR), we assessed the clinical determinants of global heart T2* values, and we explored the association between multiparametric CMR findings and cardiac complications.
Materials and methods
We considered 254 beta-TI patients (43.14 ± 13.69 years, 138 females) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia project. MIO was quantified by T2* technique and biventricular function and atrial areas by cine images. Macroscopic myocardial fibrosis was detected by late gadolinium enhancement technique.
Results
Compared to never/sporadically transfused patients, regularly transfused (RT)-TI patients exhibited significantly lower global heart T2* values, biventricular end-diastolic volume indexes, left ventricular mass index, and cardiac index. In RT-TI patients, age and serum ferritin levels were the strongest predictors of global heart T2* values. Independently from the transfusional state, cardiac T2* values were not associated with biventricular function.
Of the 103 (40.6%) patients in whom the contrast medium was administrated, 27 (26.2%) had replacement myocardial fibrosis. Age, sex distribution, cardiac iron, and biventricular function parameters were comparable between patients without and without replacement myocardial fibrosis. Twenty-five (9.8%) patients had a history of cardiac complications (heart failure and arrhythmias). Increased age and replacement myocardial fibrosis emerged as significant risk markers for cardiac complications.
Conclusions
In TI, regular transfusions are associated with less pronounced cardiac remodeling but increase the risk of MIO. Replacement myocardial fibrosis is a frequent finding associated with cardiac complications.
{"title":"Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network","authors":"Antonella Meloni, Laura Pistoia, Paolo Ricchi, Filomena Longo, Valerio Cecinati, Francesco Sorrentino, Liana Cuccia, Elisabetta Corigliano, Vincenza Rossi, Riccardo Righi, Priscilla Fina, Stefania Renne, Luigi Barbuto, Vincenzo Positano, Filippo Cademartiri","doi":"10.1007/s11547-024-01821-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01821-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>In a relatively large cohort of thalassemia intermedia (TI) patients, we systematically investigated myocardial iron overload (MIO), function, and replacement fibrosis using cardiac magnetic resonance (CMR), we assessed the clinical determinants of global heart T2* values, and we explored the association between multiparametric CMR findings and cardiac complications.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>We considered 254 beta-TI patients (43.14 ± 13.69 years, 138 females) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia project. MIO was quantified by T2* technique and biventricular function and atrial areas by cine images. Macroscopic myocardial fibrosis was detected by late gadolinium enhancement technique.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Compared to never/sporadically transfused patients, regularly transfused (RT)-TI patients exhibited significantly lower global heart T2* values, biventricular end-diastolic volume indexes, left ventricular mass index, and cardiac index. In RT-TI patients, age and serum ferritin levels were the strongest predictors of global heart T2* values. Independently from the transfusional state, cardiac T2* values were not associated with biventricular function.</p><p>Of the 103 (40.6%) patients in whom the contrast medium was administrated, 27 (26.2%) had replacement myocardial fibrosis. Age, sex distribution, cardiac iron, and biventricular function parameters were comparable between patients without and without replacement myocardial fibrosis. Twenty-five (9.8%) patients had a history of cardiac complications (heart failure and arrhythmias). Increased age and replacement myocardial fibrosis emerged as significant risk markers for cardiac complications.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>In TI, regular transfusions are associated with less pronounced cardiac remodeling but increase the risk of MIO. Replacement myocardial fibrosis is a frequent finding associated with cardiac complications.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140813010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Data from recently trials have provided practice-changing recommendations in management of the axilla in early breast cancer (eBC). However, further controversies have been raised, resulting in heterogeneous diffusion of these recommendations. Our purpose was to obtain a better homogeneity.
Material and methods
In 2021, the Tuscan Breast Network (TBN) established a consensus with the aim to update recommendations in this area. We performed a literature review on axillary management in eBC patients which led to an expert Delphi consensus aiming to explore the gray areas, build consensus and propose evidence-based suggestions for an appropriate management. Thereafter, we investigate their implementation in clinical practice.
Results
(1) DCIS patients should have SLN biopsy only in case of mastectomy or in conservative surgery if tumor is in a location that would preclude future nodal sampling or in case of a mass; (2) ALND may be omitted for 1–2 positive SLN patients undergoing BCS in T1-2 tumors with 1–2 SLN positive, eligible for whole-breast irradiation and adjuvant systemic therapies; (3) consider the option of RNI in patients with 1–3 positive lymph nodes and one or more high-risk characteristics; (4) the population identified in 2) should NOT undergo lymph node irradiation as an alternative to axillary surgery and (5) patients with clinically (pre-operatively) positive axilla, or undergoing primary systemic therapy, or outside the criteria reported in 2) must receive additional ALND and/or RT as per local policy.
Conclusion
This consensus provided a practical tool to stimulate local and national breast surgical and radiotherapy protocols.
{"title":"Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network","authors":"Matteo Ghilli, Carlotta Becherini, Icro Meattini, Catia Angiolini, Carmelo Bengala, Aroldo Marconi, Lorenzo Galli, Giovanni Angiolucci, Luigi Coltelli, Simona Borghesi, Luciana Lastrucci, Gianpiero Manca, Simonetta Bianchi, Morena Doria, Donato Casella, Lorenza Marotti, Gianni Amunni, Manuela Roncella","doi":"10.1007/s11547-024-01818-7","DOIUrl":"https://doi.org/10.1007/s11547-024-01818-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Data from recently trials have provided practice-changing recommendations in management of the axilla in early breast cancer (eBC). However, further controversies have been raised, resulting in heterogeneous diffusion of these recommendations. Our purpose was to obtain a better homogeneity.</p><h3 data-test=\"abstract-sub-heading\">Material and methods</h3><p>In 2021, the Tuscan Breast Network (TBN) established a consensus with the aim to update recommendations in this area. We performed a literature review on axillary management in eBC patients which led to an expert Delphi consensus aiming to explore the gray areas, build consensus and propose evidence-based suggestions for an appropriate management. Thereafter, we investigate their implementation in clinical practice.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>(1) DCIS patients should have SLN biopsy only in case of mastectomy or in conservative surgery if tumor is in a location that would preclude future nodal sampling or in case of a mass; (2) ALND may be omitted for 1–2 positive SLN patients undergoing BCS in T1-2 tumors with 1–2 SLN positive, eligible for whole-breast irradiation and adjuvant systemic therapies; (3) consider the option of RNI in patients with 1–3 positive lymph nodes and one or more high-risk characteristics; (4) the population identified in 2) should NOT undergo lymph node irradiation as an alternative to axillary surgery and (5) patients with clinically (pre-operatively) positive axilla, or undergoing primary systemic therapy, or outside the criteria reported in 2) must receive additional ALND and/or RT as per local policy.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>This consensus provided a practical tool to stimulate local and national breast surgical and radiotherapy protocols.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-18DOI: 10.1007/s11547-024-01816-9
Pierleone Lucatelli, Simone Ciaglia, Bianca Rocco, Gianluca De Rubeis, Guido Bolognesi, Elio Damato, Mario Corona, Pier Giorgio Nardis, Alessandro Cannavale, Paolo Ricci, Carlo Catalano
Objectives
To demonstrate in vivo redistribution of the blood flow towards HCC’s lesions by utilizing two-dimensional perfusion angiography in b-TACE procedures.
Material and methods
In total, 30 patients with 35 HCC nodules treated in the period between January 2019 and November 2021. For each patient, a post-processing software leading to a two-dimensional perfusion angiography was applied on each angiography performed via balloon microcatheter, before and after inflation. On the colour map obtained, reflecting the evolution of contrast intensity change over time, five regions of interests (ROIs) were assessed: one on the tumour (ROI-t), two in the immediate peritumoural healthy liver parenchyma (ROI-ihl) and two in the peripheral healthy liver parenchyma (ROI-phl). The results have been interpreted with a novel in silico model that simulates the hemodynamics of the hepatic arterial system.
Results
Among the ROIs drawn inside the same segment of target lesion, the time-to-peak of the ROI-t and of the ROI-ihl have a significantly higher mean value when the balloon was inflated compared with the ROIs obtained with deflated balloon (10.33 ± 3.66 s vs 8.87 ± 2.60 s (p = 0.015) for ROI-t; 10.50 ± 3.65 s vs 9.23 ± 2.70 s (p = 0.047) for ROI-ihl). The in silico model prediction time-to-peak delays when balloon was inflated, match with those observed in vivo. The numerical flow analysis shows how time-to-peak delays are caused by the obstruction of the balloon-occluded artery and the opening of intra-hepatic collateral.
Conclusion
The measurements identify predictively the flow redistribution in the hepatic arteries during b-TACE, supporting a proper positioning of the balloon microcatheter.
{"title":"Two-dimensional perfusion angiography permits direct visualization of redistribution of flow in hepatocellular carcinoma during b-TACE","authors":"Pierleone Lucatelli, Simone Ciaglia, Bianca Rocco, Gianluca De Rubeis, Guido Bolognesi, Elio Damato, Mario Corona, Pier Giorgio Nardis, Alessandro Cannavale, Paolo Ricci, Carlo Catalano","doi":"10.1007/s11547-024-01816-9","DOIUrl":"https://doi.org/10.1007/s11547-024-01816-9","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objectives</h3><p>To demonstrate in vivo redistribution of the blood flow towards HCC’s lesions by utilizing two-dimensional perfusion angiography in b-TACE procedures.</p><h3 data-test=\"abstract-sub-heading\">Material and methods</h3><p>In total, 30 patients with 35 HCC nodules treated in the period between January 2019 and November 2021. For each patient, a post-processing software leading to a two-dimensional perfusion angiography was applied on each angiography performed via balloon microcatheter, before and after inflation. On the colour map obtained, reflecting the evolution of contrast intensity change over time, five regions of interests (ROIs) were assessed: one on the tumour (ROI-t), two in the immediate peritumoural healthy liver parenchyma (ROI-ihl) and two in the peripheral healthy liver parenchyma (ROI-phl). The results have been interpreted with a novel in silico model that simulates the hemodynamics of the hepatic arterial system.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among the ROIs drawn inside the same segment of target lesion, the time-to-peak of the ROI-t and of the ROI-ihl have a significantly higher mean value when the balloon was inflated compared with the ROIs obtained with deflated balloon (10.33 ± 3.66 s vs 8.87 ± 2.60 s (<i>p</i> = 0.015) for ROI-t; 10.50 ± 3.65 s vs 9.23 ± 2.70 s (<i>p</i> = 0.047) for ROI-ihl). The in silico model prediction time-to-peak delays when balloon was inflated, match with those observed in vivo. The numerical flow analysis shows how time-to-peak delays are caused by the obstruction of the balloon-occluded artery and the opening of intra-hepatic collateral.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The measurements identify predictively the flow redistribution in the hepatic arteries during b-TACE, supporting a proper positioning of the balloon microcatheter.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140623742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-17DOI: 10.1007/s11547-024-01783-1
Zhifan Li, Xinran Liu, Ya Gao, Xingru Lu, Junqiang Lei
Objective
This study aims to evaluate the diagnostic accuracy of ultrasound imaging (US)-based radiomics for the early prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Methods
We comprehensively searched PubMed, Cochrane Library, Embase, and Web of Science databases up to 1 January 2023 for eligible studies. We assessed the methodological quality of the enrolled studies with Radiomics Quality Score (RQS) and the Quality Assessment of Diagnostic Accuracy Studies-2 tools. We performed meta-analyses to summarize the diagnostic efficacy of US-based radiomics in response to NAC in breast cancer patients.
Results
Eight studies proved eligible. Eligible studies exhibited an average RQS score of 12.88 (35.8% of the total score), with the RQS score ranging from 8 to 19. In the meta-analyses, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.87 (95% CI 0.81–0.92), 0.78 (95% CI 0.72–0.83), 4.02 (95% CI 3.18–5.08), 0.16 (95% CI 0.10–0.25), and 25.17 (95% CI 15.10–41.95), respectively. Results from subgroup analyses indicated that prospective studies apparently exhibited more optimal sensitivity than retrospective studies. Sensitivity analyses exhibited similar results to the primary analyses.
Conclusion
US-based radiomics may be a potentially crucial adjuvant method for evaluating the response of breast cancer to NAC. Due to limited data available and low quality of eligible studies, more multicenter prospective studies with rigorous methods are required to confirm our findings.
本研究旨在评估基于超声成像(US)的放射组学在早期预测乳腺癌患者对新辅助化疗(NAC)反应方面的诊断准确性。我们使用放射组学质量评分(RQS)和诊断准确性研究质量评估-2工具评估了入选研究的方法学质量。我们进行了荟萃分析,总结了基于 US 的放射组学对乳腺癌患者 NAC 的诊断效果。合格研究的平均 RQS 得分为 12.88 分(占总分的 35.8%),RQS 得分为 8 到 19 分不等。在荟萃分析中,汇总的敏感性、特异性、阳性似然比、阴性似然比和诊断几率比分别为 0.87(95% CI 0.81-0.92)、0.78(95% CI 0.72-0.83)、4.02(95% CI 3.18-5.08)、0.16(95% CI 0.10-0.25)和 25.17(95% CI 15.10-41.95)。亚组分析结果表明,前瞻性研究显然比回顾性研究具有更理想的灵敏度。结论 基于US的放射组学可能是评估乳腺癌对NAC反应的一种潜在的重要辅助方法。由于可用数据有限,且符合条件的研究质量不高,因此需要更多采用严格方法的多中心前瞻性研究来证实我们的发现。
{"title":"Ultrasound-based radiomics for early predicting response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review with meta-analysis","authors":"Zhifan Li, Xinran Liu, Ya Gao, Xingru Lu, Junqiang Lei","doi":"10.1007/s11547-024-01783-1","DOIUrl":"https://doi.org/10.1007/s11547-024-01783-1","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>This study aims to evaluate the diagnostic accuracy of ultrasound imaging (US)-based radiomics for the early prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>We comprehensively searched PubMed, Cochrane Library, Embase, and Web of Science databases up to 1 January 2023 for eligible studies. We assessed the methodological quality of the enrolled studies with Radiomics Quality Score (RQS) and the Quality Assessment of Diagnostic Accuracy Studies-2 tools. We performed meta-analyses to summarize the diagnostic efficacy of US-based radiomics in response to NAC in breast cancer patients.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Eight studies proved eligible. Eligible studies exhibited an average RQS score of 12.88 (35.8% of the total score), with the RQS score ranging from 8 to 19. In the meta-analyses, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.87 (95% CI 0.81–0.92), 0.78 (95% CI 0.72–0.83), 4.02 (95% CI 3.18–5.08), 0.16 (95% CI 0.10–0.25), and 25.17 (95% CI 15.10–41.95), respectively. Results from subgroup analyses indicated that prospective studies apparently exhibited more optimal sensitivity than retrospective studies. Sensitivity analyses exhibited similar results to the primary analyses.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>US-based radiomics may be a potentially crucial adjuvant method for evaluating the response of breast cancer to NAC. Due to limited data available and low quality of eligible studies, more multicenter prospective studies with rigorous methods are required to confirm our findings.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140612261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-16DOI: 10.1007/s11547-024-01814-x
Rahman Ud Din, Tahira Nishtar, Xiaoguang Cheng, Haisheng Yang
Objective
To develop a novel magnetic resonance imaging (MRI) phantom for producing F-score (for fat) and W-score (for water) and to evaluate the performance of these scores in assessing osteoporosis and related vertebral fractures.
Materials and methods
First, a real-time phantom consisting of oil and water tubes was manufactured. Then, 30 female volunteers (age: 62.3 ± 6.3 years) underwent lumbar spine examination with MRI (using a novel phantom) and dual-energy X-ray absorptiometry (DXA), following ethical approval. MRI phantom-based F-score and W-score were defined by normalizing the vertebral signal intensities (SIs) by the oil and water SIs of the phantom on T1- and T2-weighted images, respectively. The diagnostic performances of the new scores for assessing osteoporosis and vertebral fractures were examined using receiver operating characteristic analysis and compared with DXA-measured areal bone mineral density (DXA-aBMD).
Results
The F-score and W-score were greater in the osteoporotic patients (3.93 and 2.29) than the non-osteoporotic subjects (3.05 and 1.79) and achieved AUC values of 0.85 and 0.74 (p < 0.05), respectively, when detecting osteoporosis. Similarly, F-score and W-score had greater values for the fracture patients (3.94 and 2.53) than the non-fracture subjects (3.14 and 1.69) and produced better AUC values (0.90 for W-score and 0.79 for F-score) compared to DXA-aBMD (AUC: 0.27, p < 0.05). In addition, the F-score and W-score had a strong correlation (r = 0.77; p < 0.001).
Conclusion
A novel real-time lumber spine MRI phantom was developed, based upon which newly defined F-score and W-score were able to detect osteoporosis and demonstrated an improved ability over DXA-aBMD in differentiating patients with vertebral fractures.
{"title":"Assessing osteoporosis in postmenopausal women: preliminary results using a novel lumbar spine phantom-based MRI scoring method","authors":"Rahman Ud Din, Tahira Nishtar, Xiaoguang Cheng, Haisheng Yang","doi":"10.1007/s11547-024-01814-x","DOIUrl":"https://doi.org/10.1007/s11547-024-01814-x","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Objective</h3><p>To develop a novel magnetic resonance imaging (MRI) phantom for producing <i>F</i>-score (for fat) and <i>W</i>-score (for water) and to evaluate the performance of these scores in assessing osteoporosis and related vertebral fractures.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>First, a real-time phantom consisting of oil and water tubes was manufactured. Then, 30 female volunteers (age: 62.3 ± 6.3 years) underwent lumbar spine examination with MRI (using a novel phantom) and dual-energy X-ray absorptiometry (DXA), following ethical approval. MRI phantom-based <i>F</i>-score and <i>W</i>-score were defined by normalizing the vertebral signal intensities (SIs) by the oil and water SIs of the phantom on <i>T</i>1- and <i>T</i>2-weighted images, respectively. The diagnostic performances of the new scores for assessing osteoporosis and vertebral fractures were examined using receiver operating characteristic analysis and compared with DXA-measured areal bone mineral density (DXA-aBMD).</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The <i>F</i>-score and <i>W</i>-score were greater in the osteoporotic patients (3.93 and 2.29) than the non-osteoporotic subjects (3.05 and 1.79) and achieved AUC values of 0.85 and 0.74 (<i>p</i> < 0.05), respectively, when detecting osteoporosis. Similarly, <i>F</i>-score and <i>W</i>-score had greater values for the fracture patients (3.94 and 2.53) than the non-fracture subjects (3.14 and 1.69) and produced better AUC values (0.90 for <i>W</i>-score and 0.79 for <i>F</i>-score) compared to DXA-aBMD (AUC: 0.27, <i>p</i> < 0.05). In addition, the <i>F</i>-score and <i>W</i>-score had a strong correlation (<i>r</i> = 0.77; <i>p</i> < 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>A novel real-time lumber spine MRI phantom was developed, based upon which newly defined <i>F</i>-score and <i>W</i>-score were able to detect osteoporosis and demonstrated an improved ability over DXA-aBMD in differentiating patients with vertebral fractures.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140574023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}